Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
about
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of diseaseCell biology of spinocerebellar ataxiaNeuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protectionGenetically engineered mouse models of the trinucleotide-repeat spinocerebellar ataxias.RNA therapy for polyglutamine neurodegenerative diseases.Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis.Molecular Mechanism of Switching of TrkA/p75(NTR) Signaling in Monocrotophos Induced Neurotoxicity.Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor-dependent and -independent neuronal responses.Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice.Piperine ameliorates SCA17 neuropathology by reducing ER stress.
P2860
Q26764958-0197B815-CA19-4360-9692-413601BBD893Q26829511-F57640FE-5C6E-484A-A11B-F7BCDF683FF7Q35065692-BEE69F58-F91E-4237-8BCA-D631242056F0Q35155993-B6578603-C4EA-47CE-B5F3-E29817182268Q36890888-64C23652-5E05-412B-BEA1-33FE7C9AD9B5Q37459887-CF94FDA5-1CD1-4B44-877E-47D0EC51442DQ37910368-97640736-6030-47F4-A5EE-B18AA403A9DCQ37980319-4153DD7C-A474-4A22-A71F-7E9F4B14212EQ38450994-A42540F6-5576-4328-A4A4-CA8A190C28C0Q38818474-029EC1FB-7E4C-4356-B690-AB8548D67482Q39061798-2730837B-F4A8-41AC-AA27-CE63ED006A62Q41769119-6D6DEAFD-F75E-4991-8CBB-3D53F7029833Q42503430-F4E403C8-D06A-4A6A-A6BB-04CE7ECF5EBBQ47922788-048DF7B3-A9A1-437E-8DE2-F787F11BDBC6Q48148566-7DCFCD3F-DEF8-4F66-958D-5BB1B9BC9848
P2860
Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@en
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@nl
type
label
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@en
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@nl
prefLabel
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@en
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@nl
P2093
P2860
P356
P1476
Transcriptional dysregulation ...... pinocerebellar ataxia type 17.
@en
P2093
Anjali G Shah
Meredith Roberts
Meyer J Friedman
Shanshan Huang
Xiao-Jiang Li
P2860
P304
P356
10.1093/HMG/DDP363
P577
2009-07-30T00:00:00Z